|
1
|
Son SM: Role of vascular reactive oxygen
species in development of vascular abnormalities in diabetes.
Diabetes Res Clin Pract. 77(Suppl 1): S65–S70. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maejima Y, Kuroda J, Matsushima S, Ago T
and Sadoshima J: Regulation of myocardial growth and death by NADPH
oxidase. J Mol Cell Cardiol. 50:408–416. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Giacco F and Brownlee M: Oxidative stress
and diabetic complications. Circ Res. 107:1058–1070. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Witko-Sarsat V, Friedlander M,
Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers
P and Descamps-Latscha B: Advanced oxidation protein products as a
novel marker of oxidative stress in uremia. Kidney Int.
49:1304–1313. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Krzystek-Korpacka M, Patryn E, Boehm D,
Berdowska I, Zielinski B and Noczynska A: Advanced oxidation
protein products (AOPPs) in juvenile overweight and obesity prior
to and following weight reduction. Clin Biochem. 41:943–949. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sakul A, Cumaoğlu A, Aydin E, Ari N,
Dilsiz N and Karasu C: Age- and diabetes-induced regulation of
oxidative protein modification in rat brain and peripheral tissues:
Consequences of treatment with antioxidant pyrindole. Exp Gerontol.
48:476–484. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martín-Gallán P, Carrascosa A, Gussinyé M
and Domínguez C: Biomarkers of diabetes-associated oxidative stress
and antioxidant status in young diabetic patients with or without
subclinical complications. Free Radic Biol Med. 34:1563–1574. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Atabek ME, Keskin M, Yazici C, Kendirci M,
Hatipoglu N, Koklu E and Kurtoglu S: Protein oxidation in obesity
and insulin resistance. Eur J Pediatr. 165:753–756. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou LL, Cao W, Xie C, Tian J, Zhou Z,
Zhou Q, Zhu P, Li A, Liu Y, Miyata T, et al: The receptor of
advanced glycation end products plays a central role in advanced
oxidation protein products-induced podocyte apoptosis. Kidney Int.
82:759–770. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wei XF, Zhou QG, Hou FF, Liu BY and Liang
M: Advanced oxidation protein products induce mesangial cell
perturbation through PKC-dependent activation of NADPH oxidase. Am
J Physiol Renal Physiol. 296:F427–F437. 2009. View Article : Google Scholar
|
|
11
|
Zhou QG, Zhou M, Lou AJ, Xie D and Hou FF:
Advanced oxidation protein products induce inflammatory response
and insulin resistance in cultured adipocytes via induction of
endoplasmic reticulum stress. Cell Physiol Biochem. 26:775–786.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li HY, Hou FF, Zhang X, Chen PY, Liu SX,
Feng JX, Liu ZQ, Shan YX, Wang GB, Zhou ZM, et al: Advanced
oxidation protein products accelerate renal fibrosis in a remnant
kidney model. J Am Soc Nephrol. 18:528–538. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi XY, Hou FF, Niu HX, Wang GB, Xie D,
Guo ZJ, Zhou ZM, Yang F, Tian JW and Zhang X: Advanced oxidation
protein products promote inflammation in diabetic kidney through
activation of renal nicotinamide adenine dinucleotide phosphate
oxidase. Endocrinology. 149:1829–1839. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu SX, Hou FF, Guo ZJ, Nagai R, Zhang WR,
Liu ZQ, Zhou ZM, Zhou M, Xie D, Wang GB and Zhang X: Advanced
oxidation protein products accelerate atherosclerosis through
promoting oxidative stress and inflammation. Arterioscler Thromb
Vasc Biol. 26:1156–1162. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen S, Liu L, Sun X, Liu Y and Song T:
Captopril restores endothelium-dependent relaxation induced by
advanced oxidation protein products in rat aorta. J Cardiovasc
Pharmacol. 46:803–809. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo ZJ, Niu HX, Hou FF, Zhang L, Fu N,
Nagai R, Lu X, Chen BH, Shan YX, Tian JW, et al: Advanced oxidation
protein products activate vascular endothelial cells via a
RAGE-mediated signaling pathway. Antioxid Redox Signal.
10:1699–1712. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tal MG: Type 2 diabetes: Microvascular
ischemia of pancreatic islets? Med Hypotheses. 73:357–358. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zanone MM, Favaro E and Camussi G: From
endothelial to beta cells: Insights into pancreatic islet
microendothelium. Curr Diabetes Rev. 4:1–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Baggio LL and Drucker DJ: Biology of
incretins: GLP-1 and GIP. Gastroenterology. 132:2131–2157. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Abu-Hamdah R, Rabiee A, Meneilly GS,
Shannon RP, Andersen DK and Elahi D: Clinical review: The
extrapancreatic effects of glucagon-like peptide-1 and related
peptides. J Clin Endocrinol Metab. 94:1843–1852. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Puddu A, Storace D, Durante A, Odetti P
and Viviani GL: Glucagon-like peptide-1 counteracts the detrimental
effects of advanced glycation end-products in the pancreatic beta
cell line HIT-T 15. Biochem Biophys Res Commun. 398:462–466. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ishibashi Y, Nishino Y, Matsui T, Takeuchi
M and Yamagishi S: Glucagon-like peptide-1 suppresses advanced
glycation end product-induced monocyte chemoattractant protein-1
expression in mesangial cells by reducing advanced glycation end
product receptor level. Metabolism. 60:1271–1277. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ishibashi Y, Matsui T, Takeuchi M and
Yamagishi S: Sitagliptin augments protective effects of GLP-1
against advanced glycation end product receptor axis in endothelial
cells. Horm Metab Res. 43:731–734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Capeillere-Blandin C, Gausson V,
Descamps-Latscha B and Witko-Sarsat V: Biochemical and
spectrophotometric significance of advanced oxidized protein
products. Biochim Biophys Acta. 1689:91–102. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Arbet-Engels C, Darquy S, Capron F and
Reach G: Isolation of islets of Langerhans from the rat and pig
pancreas using a modified UW solution from organ storage to islet
purification. Diabete Metab. 19:590–596. 1993.PubMed/NCBI
|
|
26
|
Lou J, Triponez F, Oberholzer J, Wang H,
Yu D, Buhler L, Cretin N, Mentha G, Wollheim CB and Morel P:
Expression of alpha-1 proteinase inhibitor in human islet
microvascular endothelial cells. Diabetes. 48:1773–1778. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li JM, Mullen AM, Yun S, Wientjes F,
Brouns GY, Thrasher AJ and Shah AM: Essential role of the NADPH
oxidase subunit p47(phox) in endothelial cell superoxide production
in response to phorbol ester and tumor necrosis factor-alpha. Circ
Res. 90:143–150. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng S, Zhong ZM, Qin S, Chen GX, Wu Q,
Zeng JH, Ye WB, Li W, Yuan K, Yao L, et al: Advanced oxidation
protein products induce inflammatory response in fibroblast-like
synoviocytes through NADPH oxidase -dependent activation of NF-κB.
Cell Physiol Biochem. 32:972–985. 2013. View Article : Google Scholar
|
|
29
|
Garcia Soriano F, Virág L, Jagtap P, Szabó
E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL,
et al: Diabetic endothelial dysfunction: The role of
poly(ADP-ribose) polymerase activation. Nat Med. 7:108–113. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Barsotti A, Fabbi P, Fedele M, Garibaldi
S, Balbi M, Bezante GP, Risso D, Indiveri F, Ghigliotti G and
Brunelli C: Role of advanced oxidation protein products and Thiol
ratio in patients with acute coronary syndromes. Clin Biochem.
44:605–611. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Simm A, Wagner J, Gursinsky T, Nass N,
Friedrich I, Schinzel R, Czeslik E, Silber RE and Scheubel RJ:
Advanced glycation endproducts: A biomarker for age as an outcome
predictor after cardiac surgery? Exp Gerontol. 42:668–675. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gradinaru D, Borsa C, Ionescu C and
Margina D: Advanced oxidative and glycoxidative protein damage
markers in the elderly with type 2 diabetes. J Proteomics.
92:313–322. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou LL, Hou FF, Wang GB, Yang F, Xie D,
Wang YP and Tian JW: Accumulation of advanced oxidation protein
products induces podocyte apoptosis and deletion through
NADPH-dependent mechanisms. Kidney Int. 76:1148–1160. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tschen SI, Dhawan S, Gurlo T and Bhushan
A: Age-dependent decline in beta-cell proliferation restricts the
capacity of beta-cell regeneration in mice. Diabetes. 58:1312–1320.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim W and Egan JM: The role of incretins
in glucose homeostasis and diabetes treatment. Pharmacol Rev.
60:470–512. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ishibashi Y, Matsui T, Takeuchi M and
Yamagishi S: Glucagon-like peptide-1 (GLP-1) inhibits advanced
glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA
levels in endothelial cells by suppressing AGE receptor (RAGE)
expression. Biochem Biophys Res Commun. 391:1405–1408. 2010.
View Article : Google Scholar
|
|
37
|
Puddu A, Sanguineti R, Durante A, Nencioni
A, Mach F, Montecucco F and Viviani GL: Glucagon-like peptide-1
triggers protective pathways in pancreatic beta-cells exposed to
glycated serum. Mediators Inflamm. 2013:3171202013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Luciano Viviani G, Puddu A, Sacchi G,
Garuti A, Storace D, Durante A, Monacelli F and Odetti P: Glycated
fetal calf serum affects the viability of an insulin-secreting cell
line in vitro. Metabolism. 57:163–169. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Matsui T, Nishino Y, Takeuchi M and
Yamagishi S: Vildagliptin blocks vascular injury in thoracic aorta
of diabetic rats by suppressing advanced glycation end
product-receptor axis. Pharmacol Res. 63:383–388. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhan Y, Sun HL, Chen H, Zhang H, Sun J,
Zhang Z and Cai DH: Glucagon-like peptide-1 (GLP-1) protects
vascular endothelial cells against advanced glycation end products
(AGEs)-induced apoptosis. Med Sci Monit. 18:BR286–BR291. 2012.
View Article : Google Scholar : PubMed/NCBI
|
